References
1. Vorobiyova A.V. The peculiarities of chronic gastroduodenitis in children (literature review). Vestnik novykh meditsinskikh tekhnologii (Elektronnoe izdanie). 2016; 10 (1): 229-34. (in Russian)
2. Malanicheva T.G., Ziatdinova N.V., Denisova S.N. Prevalence of upper gastrointestinal tract diseases in infants and preschool children. Eksperimental’naya i klinicheskaya gastoenterologiya. 2012; 1: 55-8. (in Russian)
3. Shcherbakov P.L. Modern problems of teenage gastroenterology. Pediatriya. 2010; 89 (2): 6-11. (in Russian)
4. Tokuda Y., Takahashi O., Ohde S., Shakudo M., et al. Gastrointestinal symptoms in a Japanese population: a health diary study. World J. Gastroenterol. 2007; 13 (4): 572-8.
5. Qu X., Tang Y., Hua S. Immunological approaches towards cancer and inflammation: a cross talk. Front. Immunol. 2018; 9: 563.
6. Vshivkov V.A., Polivanova T.V., Kasparov E.V., Peretyat’ko O.V., et al. State of the mucous membrane of the gastroduodenal zone in schoolchildren of the region with a high prevalence of gastric cancer. Rossiyskiy pediatricheskiy zhurnal. 2018; 21 (1): 26-30. (in Russian)
7. Aksel’ E.M. Statistics of malignant tumors of the gastrointestinal tract. Sibirskiy onkologicheskiy zhurnal. 2017; 16 (3): 5-11. (in Russian)
8. Zhu C., Ren C., Han J., Ding Y., et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br. J. Cancer. 2014; 110 (9): 2291-9.
9. Ueda J., Gosho M., Inui Y., Matsuda T., et al. Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan. Helicobacter. 2014; 19 (2): 105-10.
10. Drossman D.A. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016; 150: 1262-79.
11. Aruin L.I., Kononov A.V., Mozgovoi S.I. International classification of chronic gastritis: what should be taken and what is in doubt. Arkhiv patologii. 2009; 71 (4): 11-7. (in Russian)
12. Dixon M.F., Genta R.M., Yardley J.H. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter. 1997; 2 (1): 17-24.
13. Sha W., Pasricha P.J., Chen J.D. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia. J. Clin. Gastroenterol. 2009; 43 (8): 716-22.
14. Tack J., Talley N.J. Gastroduodenal вisorders. Am. J. Gastroenterol. 2010; 105 (4): 757-63.
15. Geginat J., Larghi P., Paroni M., Nizzoli G., et al. The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. Cytokine Growth Factor Rev. 2016; 30: 87-93.
16. Valenzuela M.A., Canales J., Corvalán A.H., Quest A.F. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J. Gastroenterol. 2015; 21 (45): 12 742-56.
17. Noto J.M., Peek R.M. The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog. 2017; 13 (10): e1006573
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629027/
doi: 10.1371/journal.ppat.1006573
18. Siregar G.A., Halim S., Sitepu V.R. Serum TNF-a, IL-8, VEGF levels in Helicobacter pylori infection and their association with degree of gastritis. Acta Med. Indones. 2015; 47 (2): 120-6.
19. Krupa A., Fol M., Dziadek B.R., Kepka E., et al. Binding of CXCL8/IL-8 to Mycobacterium tuberculosis modulates the innate immune response. Mediators Inflamm. 2015; 2015: 124762
URL: https://www.ncbi.nlm.nih.gov/pubmed/26300588
doi: 10.1155/2015/124762
20. Dong C., Fu T., Ji J., Li Z., et al. The role of interleukin-4 in rheumatic diseases. Clin. Exp. Pharmacol. Physiol. 2018; 45 (8): 747-54.
21. Bent R., Moll L., Grabbe S., Bros M. Interleukin-1 beta-A friend or foe in malignancies? Int. J. Mol. Sci. 2018; 19 (8): E2155. doi: 10.3390/ijms19082155.
URL: https://www.ncbi.nlm.nih.gov/pubmed/30042333
doi: 10.3390/ijms19082155